Director, Division of Cancer Prevention & Control
Dr. Paskett became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is a professor in the Division of Epidemiology in the College of Public Health and the associate director for Population Sciences and program leader of the Cancer Control Program in The Ohio State University Comprehensive Cancer Center (OSUCCC). She is also director of the Center for Cancer Health Equity at The James.
Dr. Brasky is a research assistant professor in the Division of Cancer Prevention and Control. His research interests focus on developing a further understanding of the association of inflammation and cancer. Specifically he is interested in the study of substances and genes hypothesized to affect inflammation. In addition to working with other researchers as well as clinical colleagues, he has an expanding interest in the study of diet and dietary supplements, components of which may affect inflammatory processes, and their association with cancer risk and survival.
Dr. Naughton's research focuses on psychosocial issues and quality of life in cancer populations. She is currently the principal investigator on three studies in the Alliance assessing quality of life related to cancer treatment, one in the area of colorectal cancer and two in the area of breast cancer. In addition, Dr. Naughton is the past principal investigator of a Behavioral Center of Excellence in Breast Cancer funded by the Department of Defense.
Dr. Reiter's research addresses cancer prevention and control through two main thematic areas: cancer screening and vaccination. Both health behaviors are effective strategies for reducing disease burden, yet remain underutilized. He is particularly interested in examining the determinants of engaging in these behaviors and designing programs to increase their use.
Dr. Shields is an internationally renowned physician-scientist and expert in cancer prevention. He serves as a professor in the College of Medicine and is the deputy director of the OSUCCC. Dr. Shields is a leader in researching new biomarkers of cancer risk, molecular epidemiology and carcinogenesis. His primary focus is identifying biomarkers that can be used in the clinic to assess breast and lung cancer risk, particularly those related to diet, smoking and lifestyle, as well as to assess tobacco-related toxicity and development of methods to assess new tobacco products.